Quarterly report pursuant to Section 13 or 15(d)

Prepaid Expenses and Other Current Assets (Tables)

v3.21.2
Prepaid Expenses and Other Current Assets (Tables)
9 Months Ended
Sep. 30, 2021
Prepaid Expense And Other Assets Current [Abstract]  
Summary of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following:

 

 

 

September 30,

2021

 

 

December 31,

2020

 

Refundable FDA filing fee (1)

 

$

 

 

$

2,876

 

Short-term deposits

 

 

2,293

 

 

 

2,360

 

Prepaid insurance

 

 

954

 

 

 

415

 

Research and development tax credit receivable

 

 

877

 

 

 

801

 

Interest receivable

 

 

136

 

 

 

 

Other prepaid assets

 

 

132

 

 

 

231

 

Prepaid research and development expenses

 

 

51

 

 

 

157

 

Value added tax receivable

 

 

14

 

 

 

64

 

Deferred financing expenses

 

 

45

 

 

 

 

Total

 

$

4,502

 

 

$

6,904

 

(1) FDA filing fee refund of $2,876 was received in January 2021